← back to search

V. Craig Jordan

The University of Texas MD Anderson Cancer Center · US
Area of research
Genetics · Cancer Research
Research interest
Research interests include Estrogen and related hormone effects, Breast Cancer Treatment Studies, Inflammatory mediators and NSAID effects, and Menopause: Health Impacts and Treatments.
h-index
85
citations
26,279
works
572
NIH funding
primary concept
email

Recent publications

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
Breast Cancer Research 2023cited by 32position: middledoi
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.
2021cited by 6position: contributordoi
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells
Molecular Pharmacology 2020cited by 23position: lastdoi
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer
Molecular Cancer Therapeutics 2020cited by 14position: lastdoi
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
Exploration of Targeted Anti-tumor Therapy 2020cited by 7position: middledoi
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer.
2020cited by 7position: contributordoi
Abstract 1689: Comparative whole genome analyses of breast cancer aromatase inhibitor resistance models
Molecular and Cellular Biology / Genetics 2019cited by 0position: middledoi
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer
Molecular Pharmacology 2018cited by 51position: lastdoi
Profiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer
Oncotarget 2016cited by 14position: middledoi
Abstract 1073: Modulation of aromatase inhibitor resistance by miRNAs in breast cancer
Cancer Research 2016cited by 1position: middledoi
Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer
Molecular Cancer Therapeutics 2014cited by 20position: middledoi
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations
Clinical Pharmacology & Therapeutics 2013cited by 174position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ping Fan · University of Science and Technology of China7 papers (2016–2020)Philipp Y. Maximov · Moscow Institute of Physics and Technology5 papers (2014–2020)Balkees Abderrahman · The University of Texas MD Anderson Cancer Center4 papers (2018–2020)Hiltrud Brauch · German Cancer Research Center4 papers (2016–2020)Reiner Hoppe · Pomeranian Medical University4 papers (2016–2020)Ramona Curpăn · Romanian Academy3 papers (2018–2020)Sean W. Fanning · Loyola University Chicago3 papers (2018–2020)Heather E. Cunliffe · University of Otago3 papers (2016–2019)Geoffrey L. Greene · University of Chicago3 papers (2018–2020)Bradley M. Broom · The University of Texas MD Anderson Cancer Center2 papers (2020–2020)Anna Malovannaya · Baylor College of Medicine2 papers (2020–2020)Gregory R. J. Thatcher · University of Illinois Chicago2 papers (2014–2020)Antrix Jain · Baylor College of Medicine2 papers (2020–2020)Charles E. Foulds · Baylor College of Medicine2 papers (2020–2020)Florian Büttner · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology2 papers (2016–2016)Rui Xiong · University of Illinois Chicago2 papers (2014–2020)Jeffery A. Greenland · University of Utah2 papers (2018–2020)Stefan Winter · University of Tübingen2 papers (2016–2016)Daniela Maria Quintana Rincon · The University of Texas MD Anderson Cancer Center2 papers (2018–2020) · 2 papers (2020–2021)